Prognostic capability of the Maximum Acute Gastrointestinal Injury Score and of caloric intake in patients requiring vasopressors: A multicenter prospective cohort study

J Crit Care. 2020 Aug:58:41-47. doi: 10.1016/j.jcrc.2020.04.007. Epub 2020 Apr 16.

Abstract

Purpose: Our main objective was to use the Maximum Acute Gastrointestinal Injury Score (AGImax) to evaluate the prognostic capability of gastrointestinal dysfunction (GID), on hospital mortality in patients on mechanical ventilation (MV) requiring vasopressors. A secondary goal was to analyze the relationship between AGImax and vasopressor dosage with increasing caloric intake.

Materials and methods: Prospective multicenter cohort study in ten ICUs across Argentina. Consecutive adult patients on MV, requiring vasopressors and receiving enteral nutrition (EN) were included. AGImax was identified (I-IV) using a modified AGI score. Comparisons of clinical and outcome variables were performed in 3 predetermined EN-groups: <10 kcal/kg/d, ≥10 to <20 kcal/kg/d, or ≥ 20 kcal/kg/d.

Results: A total of 494 patients met all inclusion criteria. Forty-four percent of patients had severe AGImax and 17% received <10 kcal/kg/day, indicating more severity and higher mortality. Notable independent predictors of mortality were AGImax, vasopressors, and caloric intake. PN was the only factor which had an inverse relationship to mortality.

Conclusions: In this population, patients with AGImax III-IV were significantly associated with lower caloric intake and greater hospital mortality, highlighting the importance of AGI as a prognostic tool. As PN was linked with lower mortality, it could be an option to explore in further studies.

Keywords: Acute gastrointestinal injury score; Caloric intake; Gastrointestinal dysfunction; Hospital mortality; Vasopressors.

Publication types

  • Evaluation Study
  • Multicenter Study

MeSH terms

  • Adult
  • Argentina
  • Cohort Studies
  • Energy Intake*
  • Female
  • Gastrointestinal Tract / injuries*
  • Humans
  • Injury Severity Score*
  • Middle Aged
  • Predictive Value of Tests
  • Prognosis
  • Prospective Studies
  • Respiration, Artificial
  • Shock / mortality
  • Shock / therapy*
  • Vasopressins / administration & dosage
  • Vasopressins / therapeutic use*

Substances

  • Vasopressins